 CytoDyn Inc OTCQB:CYDY, which is developing Vyrologix leronlimab-PRO 140 for multiple indications, revealed that Chiral Pharma Corporation placed its first purchase order for leronlimab under a compassionate special permit CSP, to treat critically ill coronavirus COVID-19 patients in the Philippines. The Vancouver, Washington-based late-stage biotech will earn revenue after order fulfillment and the terms of the agreement are ironed out. 